AIManage Using an AI-driven CDS and Chatbot

The objective of this project is to define and test the GenAI-powered Clinical Decision Support (CDS) tool, AIManage, providing a broad range of incretin mimetic medication management services to optimize dose titrations. The study will take place across primary care and obesity medicine clinics at NYUH. The study is currently conducting formative data collection for tool refinement (Phase 1). Once completed, a cluster randomized controlled trial of the AIManage tool will be undertaken (Phase 2).

NCT Number	NCT07546357
Lead Sponsor	NYU Langone Health Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions	Diabetes, Obesity, Medication Side Effects
Enrollment	16 participants
Start Date	2026-06-01
Primary Completion	2028-03-30 (estimated)
Study Completion	2029-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-22